Early mortality in multiple myeloma

被引：34

作者：

Costa, L. J. ^{[1
]}

Gonsalves, W. I. ^{[2
]}

Kumar, S. K. ^{[2
]}

机构：

[1] Univ Alabama Birmingham, Dept Med, Div Hematol & Oncol, Birmingham, AL 35294 USA

[2] Mayo Clin, Dept Med, Div Hematol, Rochester, MN USA

来源：

LEUKEMIA | 2015年 / 29卷 / 07期

关键词：

STEM-CELL TRANSPLANTATION; THALIDOMIDE PLUS DEXAMETHASONE; RANDOMIZED CONTROLLED-TRIAL; LONG-TERM SURVIVAL; INDUCTION TREATMENT; ELDERLY-PATIENTS; INITIAL THERAPY; BORTEZOMIB; PREDNISONE; MELPHALAN;

D O I：

10.1038/leu.2015.33

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1616 / 1618

页数：3

共 18 条

[1] Recent major improvement in long-term survival of younger patients with multiple myeloma [J].

Brenner, Hermann ;

Gondos, Adam ;

Pulte, Dianne .

BLOOD, 2008, 111 (05) :2521-2526

[2] Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial [J].

Facon, Thierry ;

Mary, Jean Yves ;

Hulin, Cyrille ;

Benbouker, Lofti ;

Attal, Michel ;

Pegourie, Brigitte ;

Renaud, Marc ;

Guillerm, Jean Luc Harousseau Gaelle ;

Ahletaix, Carine ;

Dib, Mamoun ;

Voillat, Laurent ;

Maisonneuve, Herve ;

Troncy, Jacques ;

Dervaux, Weronique ;

Monconduit, Mathieu ;

Martin, Claude ;

Casassus, Philippe ;

Jaubert, Jerome ;

Jardel, Henry ;

Doyen, Chantal ;

Kolb, Brigitte ;

Anglaret, Bruno ;

Grosbois, Bernard ;

Yakoub-Agha, Ibrahim ;

Mathiot, Claire ;

Avet-Loiseau, Herve .

LANCET, 2007, 370 (9594) :1209-1218

[3] Bortezomib Plus Dexamethasone Is Superior to Vincristine Plus Doxorubicin Plus Dexamethasone As Induction Treatment Prior to Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: Results of the IFM 2005-01 Phase III Trial [J].

Harousseau, Jean-Luc ;

Attal, Michel ;

Avet-Loiseau, Herve ;

Marit, Gerald ;

Caillot, Denis ;

Mohty, Mohamad ;

Lenain, Pascal ;

Hulin, Cyrille ;

Facon, Thierry ;

Casassus, Philippe ;

Michallet, Mauricette ;

Maisonneuve, Herve ;

Benboubker, Lotfi ;

Maloisel, Frederic ;

Petillon, Marie-Odile ;

Webb, Iain ;

Mathiot, Claire ;

Moreau, Philippe .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (30) :4621-4629

[4] Improved long-term survival in multiple myeloma up to the age of 80 years [J].

Kristinsson, S. Y. ;

Anderson, W. F. ;

Landgren, O. .

LEUKEMIA, 2014, 28 (06) :1346-1348

[5] Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients [J].

Kumar, S. K. ;

Dispenzieri, A. ;

Lacy, M. Q. ;

Gertz, M. A. ;

Buadi, F. K. ;

Pandey, S. ;

Kapoor, P. ;

Dingli, D. ;

Hayman, S. R. ;

Leung, N. ;

Lust, J. ;

McCurdy, A. ;

Russell, S. J. ;

Zeldenrust, S. R. ;

Kyle, R. A. ;

Rajkumar, S. V. .

LEUKEMIA, 2014, 28 (05) :1122-1128

[6] Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial [J].

Mateos, Maria-Victoria ;

Oriol, Albert ;

Martinez-Lopez, Joaquin ;

Gutierrez, Norma ;

Teruel, Ana-Isabel ;

de Paz, Raquel ;

Garcia-Larana, Jose ;

Bengoechea, Enrique ;

Martin, Alejandro ;

Diaz Mediavilla, Joaquin ;

Palomera, Luis ;

de Arriba, Felipe ;

Gonzalez, Yolanda ;

Hernandez, Jose-Mariano ;

Sureda, Ana ;

Bello, Jose-Luis ;

Bargay, Joan ;

Penalver, Francisco-Javier ;

Ribera, Jose-Maria ;

Martin-Mateos, Maria-Luisa ;

Garcia-Sanz, Ramon ;

Cibeira, Maria-Teresa ;

Martin Ramos, Maria-Luisa ;

Vidriales, Maria-Belen ;

Paiva, Bruno ;

Montalban, Maria-Angeles ;

Lahuerta, Juan-Jose ;

Blade, Joan ;

San Miguel, Jesus-Fernando .

LANCET ONCOLOGY, 2010, 11 (10) :934-941

[7] Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myeloma [J].

Moreau, Philippe ;

Avet-Loiseau, Herve ;

Facon, Thierry ;

Attal, Michel ;

Tiab, Mourad ;

Hulin, Cyrille ;

Doyen, Chantal ;

Garderet, Laurent ;

Randriamalala, Edouard ;

Araujo, Carla ;

Lepeu, Gerard ;

Marit, Gerald ;

Caillot, Denis ;

Escoffre, Martine ;

Lioure, Bruno ;

Benboubker, Lotfi ;

Pegourie, Brigitte ;

Kolb, Brigitte ;

Stoppa, Anne Marie ;

Fuzibet, Jean-Gabriel ;

Decaux, Olivier ;

Dib, Mamoun ;

Berthou, Christian ;

Chaleteix, Carine ;

Sebban, Catherine ;

Traulle, Catherine ;

Fontan, Jean ;

Wetterwald, Marc ;

Lenain, Pascal ;

Mathiot, Claire ;

Harousseau, Jean-Luc .

BLOOD, 2011, 118 (22) :5752-5758

[8] First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial [J].

Morgan, Gareth J. ;

Davies, Faith E. ;

Gregory, Walter M. ;

Cocks, Kim ;

Bell, Sue E. ;

Szubert, Alex J. ;

Navarro-Coy, Nuria ;

Drayson, Mark T. ;

Owen, Roger G. ;

Feyler, Sylvia ;

Ashcroft, A. John ;

Ross, Fiona ;

Byrne, Jennifer ;

Roddie, Huw ;

Rudin, Claudius ;

Cook, Gordon ;

Jackson, Graham H. ;

Child, J. Anthony .

LANCET, 2010, 376 (9757) :1989-1999

[9] Participation in cancer clinical trials - Race-, sex-, and age-based disparities [J].

Murthy, VH ;

Krumholz, HM ;

Gross, CP .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (22) :2720-2726

[10] Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled-trial [J].

Palumbo, A ;

Bringhen, S ;

Coravito, T ;

Merla, E ;

Capporella, V ;

Callea, V ;

Cangialosi, C ;

Grasso, M ;

Rossini, F ;

Galli, M ;

Catalano, L ;

Zamagni, E ;

Petrucci, MT ;

De Stefano, V ;

Ceccarelli, M ;

Ambrosini, MT ;

Avonto, I ;

Falco, P ;

Ciccone, G ;

Liberati, AM ;

Musto, P ;

Boccadoro, M .

LANCET, 2006, 367 (9513) :825-831

← 1 2 →